************************************
E-DRUG: Production Times and costs of Drug Development
I suggest that you make contact with Prof. Louis Lasagna's Center for the
Study of Drug Development at Tufts University School of Medicine in
Boston. His Center has been studying a number of these issues for more
than a decade. The address is 192 South St, Boston MA 02111. Direct
your inquiries to Dr Joseph Di Masi, who has done most of the hands-on
work in this area in recent years.
regards, by the way, to Philip Brown.
John Urquhart MD
Prof. of Pharmaco-epidemiology
Maastricht University
Maastricht, NL
On Wed, 13 May 1998, admin wrote:
> >From Stephen Dockerill infocentre@pjbpubs2.demon.co.uk
> Sender: owner-e-drug@usa.healthnet.org
> Precedence: bulk
> Reply-To: e-drug@usa.healthnet.org
> Errors-To: owner-e-drug@usa.healthnet.org
>
> ********************************************************
> E-DRUG Production Times and costs of Drug Development
>
>
> I have been asked to colliate data on the costs and development
> time of new drugs, to be included in CMR/Scrips "The Pharmaceutical R&D
> Compendium".
>
> Can anybody give me data on the following
>
> Attrition rates during the development of new drugs
>
> Benchmarking
>
> How many companies are outsourcing and Contract research organisations
> and how much it costs
>
> The costs and time taken to get approvial from the regulatory
> authorities
>
> The number of NCE's/NME's/biologics developed
>
> Staffing levels within the R&D depts of pharmaceutical companies and
> pharmacetical research institutes
>
> The costs and time taken to run preclinical, phase I,II,III & IV
> clinical trails
>
> The costs of Scaling up production of the drugs
>
> and cost and contribution of biotechnology/molecular biology towards
> developing new drugs
>
> Please send your replies to
>
> infocentre@pjbpubs2.demon.co.uk or
> annette@pjbpubs.demon.co.uk
>
> Thank you for any help that you can give in advance
>
> Kind regards
>
> Stephen Dockerill
>
>
>
>
>
> --
> Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'.
> Mail administrative requests to `majordomo@usa.healthnet.org'.
> For additional assistance, send mail to: `owner-e-drug@usa.healthnet.org'.
>
--
Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'.
Mail administrative requests to `majordomo@usa.healthnet.org'.
For additional assistance, send mail to: `owner-e-drug@usa.healthnet.org'.
|